PraXsyn Corporation Press Releases
IRVINE, Calif., Feb. 17, 2015 -- Praxsyn Corporation's (OTCQB:PXYN) wholly owned subsidiary, Mesa Pharmacy Inc. (Mesa), entered into a Script Processing Service Contract with NHS Pharma, Inc. (NHS), on October 11, 2014 to process Mesa's preferred provider organization (PPO) claims.
IRVINE, Calif., Jan. 13, 2015 -- Praxsyn Corporation (OTCQB:PXYN) today announced that it has completed the expansion of its corporate offices in Irvine. The new office space allows the company to accommodate the rapid growth experienced over the past year and will allow for future expansion plans as the company continues to make progress toward its goal of dispensing customized medications nationwide.
IRVINE, Calif., Dec. 18, 2014 -- Praxsyn Corporation (PXYN), the parent company of Mesa Pharmacy, today announced that it has begun to process PPO prescriptions. Mesa Pharmacy is dedicated to providing medical practitioners with medications for patients through this move into the PPO network with its new and advanced products.
IRVINE, Calif., November 5, 2014 – Praxsyn Corporation (OTCQB: PXYN) announced today that the majority of its shareholders have voted to change domiciles from the state of Illinois to Nevada. Praxsyn Corporation shareholders entitled to vote authorized the change of domicile via their majority written consent due to: a) Nevada’s favorable corporate laws; b) lower corporate income taxes; and c) easily accessible corporate filings through the Nevada Secretary of State’s web portal.
IRVINE, Calif., Oct. 23, 2014 -- The Praxsyn Corporation Board of Directors (PXYN), has appointed Broadridge to provide comprehensive registrar and transfer agent services for Praxsyn shareholders effective October 1, 2014.
IRVINE, Calif., October 9, 2014 – Praxsyn Corporation (OTCQB: PXYN), has appointed Kelly Reynolds to the position of Chief Executive Officer and Manager of NexGen Med Solutions, LLC, a wholly owned subsidiary of Praxsyn Corporation.
IRVINE, Calif., Sept. 5, 2014 -- Praxsyn Corporation (OTCQB:PXYN), a medication and service provider for medical practitioners, announced that it has received approval from the Financial Industry Regulatory Authority ("FINRA") for an official change in the name of the Company effective at the open of business on September 5, 2014. As previously announced, the Company changed its name to Praxsyn Corporation and will now trade under the symbol "PXYN".